A 50-kDa ERK-like protein is up-regulated by a dual altered peptide ligand that suppresses myasthenia gravis-associated responses

Eitemau Tebyg

• A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas–FasL-mediated apoptosis
  gan: Venkata Aruna, Badiga, et al.
  Cyhoeddwyd: (2006)
• The role of CD8(+)CD28(−) regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand
  gan: Ben-David, Hava, et al.
  Cyhoeddwyd: (2007)
• Suppression of myasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4(+)CD25(+) regulatory cells
  gan: Aruna, Badiga Venkata, et al.
  Cyhoeddwyd: (2005)
• The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes
  gan: Paas-Rozner, Miri, et al.
  Cyhoeddwyd: (2001)
• Down-regulation of myasthenogenic T cell responses by a dual altered peptide ligand via CD4(+)CD25(+)-regulated events leading to apoptosis
  gan: Ben-David, Hava, et al.
  Cyhoeddwyd: (2005)